Mike J. Warwick

1.0k total citations
14 papers, 873 citations indexed

About

Mike J. Warwick is a scholar working on Surgery, Pharmacology and Economics and Econometrics. According to data from OpenAlex, Mike J. Warwick has authored 14 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 4 papers in Pharmacology and 4 papers in Economics and Econometrics. Recurrent topics in Mike J. Warwick's work include Lipoproteins and Cardiovascular Health (10 papers), Inflammatory mediators and NSAID effects (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Mike J. Warwick is often cited by papers focused on Lipoproteins and Cardiovascular Health (10 papers), Inflammatory mediators and NSAID effects (4 papers) and Health Systems, Economic Evaluations, Quality of Life (3 papers). Mike J. Warwick collaborates with scholars based in United Kingdom, United States and Sweden. Mike J. Warwick's co-authors include Aaron Dane, Paul Martin, Dennis W. Schneck, P. J. Phillips, Steve Hill, Eva M. Lenz, Mireille Cantarini, Ali Raza, Kevin D. Cooper and Ali Raza and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Atherosclerosis and British Journal of Clinical Pharmacology.

In The Last Decade

Mike J. Warwick

14 papers receiving 840 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mike J. Warwick United Kingdom	12	485	247	213	200	125	14	873
Lloyd R. Whitfield United States	19	359 0.7×	325 1.3×	117 0.5×	216 1.1×	58 0.5×	48	1.2k
Yue Qiu China	12	550 1.1×	233 0.9×	122 0.6×	247 1.2×	146 1.2×	25	1.1k
Julie Zalikowski United States	6	287 0.6×	169 0.7×	100 0.5×	116 0.6×	77 0.6×	7	516
Teemu Kantola Finland	8	426 0.9×	355 1.4×	175 0.8×	538 2.7×	49 0.4×	10	1.2k
Ali Raza United States	10	553 1.1×	103 0.4×	255 1.2×	66 0.3×	151 1.2×	30	812
Hideki Fujino Japan	20	377 0.8×	579 2.3×	75 0.4×	508 2.5×	152 1.2×	36	1.1k
Carl Kyrklund Finland	6	315 0.6×	404 1.6×	77 0.4×	320 1.6×	66 0.5×	6	820
Raju D. Amin United States	13	262 0.5×	108 0.4×	74 0.3×	167 0.8×	47 0.4×	16	809
Samuel G. Johnson United States	18	261 0.5×	157 0.6×	157 0.7×	532 2.7×	62 0.5×	36	1.3k
Jenni E. Keskitalo Finland	8	330 0.7×	440 1.8×	44 0.2×	240 1.2×	91 0.7×	8	764

Countries citing papers authored by Mike J. Warwick

Since Specialization

Citations

This map shows the geographic impact of Mike J. Warwick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike J. Warwick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike J. Warwick more than expected).

Fields of papers citing papers by Mike J. Warwick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike J. Warwick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike J. Warwick. The network helps show where Mike J. Warwick may publish in the future.

Co-authorship network of co-authors of Mike J. Warwick

This figure shows the co-authorship network connecting the top 25 collaborators of Mike J. Warwick. A scholar is included among the top collaborators of Mike J. Warwick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mike J. Warwick. Mike J. Warwick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Simonson, Steven G., Paul Martin, Mike J. Warwick, Pat Mitchell, & Dennis W. Schneck. (2004). The effect of rosuvastatin on oestrogen & progestin pharmacokinetics in healthy women taking an oral contraceptive. British Journal of Clinical Pharmacology. 57(3). 279–286. 23 indexed citations

Simonson, Steven G., et al.. (2003). Pharmacokinetics and pharmacodynamics of rosuvastatin in subjects with hepatic impairment. European Journal of Clinical Pharmacology. 58(10). 669–675. 52 indexed citations

Martin, Paul, et al.. (2003). Lack of effect of ketoconazole on the pharmacokinetics of rosuvastatin in healthy subjects. British Journal of Clinical Pharmacology. 55(1). 94–99. 77 indexed citations

Martin, Paul, et al.. (2003). The effect of erythromycin on the pharmacokinetics of rosuvastatin. European Journal of Clinical Pharmacology. 59(1). 51–56. 77 indexed citations

Martin, Paul, Mike J. Warwick, Aaron Dane, et al.. (2003). Metabolism, excretion, and pharmacokinetics of rosuvastatin in healthy adult male volunteers. Clinical Therapeutics. 25(11). 2822–2835. 233 indexed citations

Martin, Paul, Mike J. Warwick, Aaron Dane, & Mireille Cantarini. (2003). A double-blind, randomized, incomplete crossover trial to assess the dose proportionality of rosuvastatin in healthy volunteers. Clinical Therapeutics. 25(8). 2215–2224. 48 indexed citations

Cooper, Kevin D., Paul Martin, Aaron Dane, et al.. (2002). The effect of fluconazole on the pharmacokinetics of rosuvastatin. European Journal of Clinical Pharmacology. 58(8). 527–531. 92 indexed citations

Martín, Paul, et al.. (2002). No Effect of Age or Gender on the Pharmacokinetics of Rosuvastatin: A New HMG-CoA Reductase Inhibitor. The Journal of Clinical Pharmacology. 42(10). 1116–1121. 64 indexed citations

Martin, Paul, John Kemp, Aaron Dane, Mike J. Warwick, & Dennis W. Schneck. (2002). No Effect of Rosuvastatin on the Pharmacokinetics of Digoxin in Healthy Volunteers. The Journal of Clinical Pharmacology. 42(12). 1352–1357. 42 indexed citations

10.

Martin, Paul, et al.. (2002). No Effect of Age or Gender on the Pharmacokinetics of Rosuvastatin: A New HMG‐CoA Reductase Inhibitor. The Journal of Clinical Pharmacology. 42(10). 1116–1121. 80 indexed citations

11.

Warwick, Mike J., Aaron Dane, Ali Raza, & Dennis W. Schneck. (2000). Single- and multiple-dose pharmacokinetics and safety of the new HMG-CoA reductase inhibitor ZD4522. Atherosclerosis. 151(1). 39–39. 57 indexed citations

12.

Warwick, Mike J., et al.. (1999). Design of a phase II efficacy trial for a GPIIb/IIIa antagonist using computer simulation. Clinical Pharmacology & Therapeutics. 65(2). 182–182. 1 indexed citations

13.

Cockshott, I. D., et al.. (1991). The pharmacokinetics of Casodex in laboratory animals. Xenobiotica. 21(10). 1347–1355. 26 indexed citations

14.

Bates, Margaret L., Mike J. Warwick, & George Shearer. (1985). Determination of synthetic growth promoters in bile. Food Additives & Contaminants. 2(1). 37–46. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact